FMR LLC 13D and 13G filings for BioXcel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-10 10:47 am Sale |
2024-09-09 | 13G | BioXcel Therapeutics, Inc. BTAI |
FMR LLC | 67,208 2.639% |
-90,203 (-57.30%) |
Filing |
| 2024-02-09 08:35 am Sale |
2024-02-08 | 13G | BioXcel Therapeutics, Inc. BTAI |
FMR LLC | 157,410 8.603% |
-11,385 (-6.74%) |
Filing |
| 2023-10-13 4:01 pm Sale |
2023-10-09 | 13G | BioXcel Therapeutics, Inc. BTAI |
FMR LLC | 168,795 9.227% |
-93,919 (-35.75%) |
Filing |
| 2023-02-09 08:23 am Purchase |
2023-02-09 | 13G | BioXcel Therapeutics, Inc. BTAI |
FMR LLC | 262,715 14.999% |
399 (+0.15%) |
Filing |
| 2022-02-09 09:09 am Purchase |
2022-02-08 | 13G | BioXcel Therapeutics, Inc. BTAI |
FMR LLC | 262,316 14.999% |
67,640 (+34.74%) |
Filing |
| 2021-07-12 12:07 pm Purchase |
2021-07-09 | 13G | BioXcel Therapeutics, Inc. BTAI |
FMR LLC | 194,676 11.021% |
69,552 (+55.59%) |
Filing |
| 2021-02-08 10:17 am Purchase |
2021-02-05 | 13G | BioXcel Therapeutics, Inc. BTAI |
FMR LLC | 125,124 8.215% |
68,212 (+119.86%) |
Filing |